CClinicalTrials.gg
CompletedNCT03459066Updated Nov 3, 2020

Predictors Factors and Time of Onset of Spasticity and Their Relationship With the Functionality and Quality of Life.

An observational study in Post Stroke Spasticity, sponsored by Universidad de La Frontera. Completed at 1 site in Chile. Open to participants aged 20 Years to 80 Years. Per ClinicalTrials.gov, last updated 2020-11-03.

Sponsored by Universidad de La Frontera · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
100
Ages
20 Years to 80 Years
Sex
All
01

Study summary

Spasticity is part of the syndrome motor neuron following a Stroke. It is a clinical sign of great complexity that generates disability, limiting the function and altering the quality of life of the subjects, generating great impact on families and society.

Identify times and characteristics of appearance; as well as its predictive factors can support an early intervention, orienting and strengthening the work of the rehabilitation team.

Determine the times of establishment, location and factors that favor the development of spasticity in acute stage and how it influences the functionality, quality of life and emotional level of post-stroke patients in hospital facilities.

Through this proposal, it is proposed to generate a new line of research that allows the development of scientific evidence in the area of neurorehabilitation, specifically in the field of spasticity, through the identification of establishment times, affected structures and predominant patterns in the extremities; as well as determining factors that favor the development of spasticity and its impact on post-stroke functionality and quality of life.

This information will strengthen the rehabilitative process of these subjects and the actions of the rehabilitation team, supporting the identification of preventive measures and implementing effective interventions that allow achieving better motor and functional results, in search of an optimal recovery.

Read the detailed description

A correlational (non-experimental), longitudinal, prospective follow-up design will be used for descriptive and predictive purposes.

The sample will consist of 150 subjects who meet the inclusion criteria, sign the informed consent and who will be treated during the year 2018 at the Hospital and the Clinic.

The study will include three measurement times: Time 1, during the first 10 days of hospitalization (T1); Time 2, at 3 months after T1; and Time 3, at 12 months after T1.

At each time of measurement, the study variables will be evaluated by 4 professionals trained in the following instruments: the Ashworth Scale to assess spasticity; To measure global functionality, the Barthel Index will be applied and, to assess functionality of the upper extremity, the Action Research Arm scale will be used; The Quality of Life Scale for Stroke-38 will be used to assess quality of life and emotional level. In addition, in time 1 the sociodemographic and clinical characteristics of the sample will be evaluated through a clinical record prepared for this purpose.

02

Conditions studied

  • Post Stroke Spasticity

Keywords

  • Spasticity
  • Stroke
  • Predictors
  • Functionality
  • Quality of life
03

Who can participate

Ages eligible
20 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

It will be constituted by all the subjects with a medical diagnosis of stroke in the acute phase, attended during 2018 at the Dr. Hernán Henríquez Aravena Hospital and the Alemana Clinic.

Inclusion criteria

  • Have an age between 20 and 80 years, with no previous history of motor disability.
  • Being hospitalized with a diagnosis of ischemic or hemorrhagic stroke in the acute period.
  • Present a history with a single stroke event confirmed by Computerized Axial Tomography.
  • Without severe cognitive commitment, that is, score greater than 14 on the MiniMental Abbreviated scale.
  • Stable hemodynamically.
  • Voluntarily accept participation in the study through the signing of informed consent, either personally or through a family member.

Exclusion criteria

Exclusion Criteria:

  • Present sensitive aphasia.
  • Have a medical contraindication.
04

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
100 participants (actual)
Target follow-up
1 Year
Patient registry
Yes

Groups and cohorts

  • Institution-Group 8 district

    Group of patients belonging to institutions of district 8. Patients will be evaluated in 3 different times with different assessment instruments for tone, functionality and quality of life.

    Diagnostic Test: Institution-Group

  • Institution-Group 9 district

    Group of patients belonging to institutions of district 9. Patients will be evaluated in 3 different times with different assessment instruments for tone, functionality and quality of life.

    Diagnostic Test: Institution-Group

  • Institution-Group 10 district

    Group of patients belonging to institutions of district 10. Patients will be evaluated in 3 different times with different assessment instruments for tone, functionality and quality of life.

    Diagnostic Test: Institution-Group

Interventions

  • Diagnostic testInstitution-Group

    The study includes three measurement times: * Time 1 (T1): corresponds to the first measurement, which will take place between the 3rd and 10th day of hospitalization. * Time 2 (T2): corresponds to the second measurement, which will be carried out 3 months after the first measurement. * Time 3 (T3): corresponds to the third measurement, which will be carried out 12 months after the first measurement. The evaluations will be tone, functionality and quality of life.

05

What researchers measure

Primary outcomes

  1. Ashworth Scale

    Instrument used in the assessment of spasticity. Graduates the tone from 0 (no increase in tone) to 4 (rigid extremity in flexion or extension), it is based on the examiner manually moving a limb of the patient, in the whole of the possible joint range (in the clinical setting it is use 1 second to perform the complete joint travel) and perceive the resistance that a muscle offers when stretched.

    Time frame: 6 months

  2. Action Research Arm

    This Instrument was constructed to determine the functional recovery of the upper limb. It is composed of 19 items grouped in 4 subtest, including each subtest: 6 items of grip, 4 items taken, 6 items of clip, 3 items of thick movement. All the items are evaluated with a scale of 4 points from 0 to 3, where 0 represents no movement and 3 normal movement for the task.

    Time frame: 6 months

  3. Barthel Index

    Scale that assesses the level of patient independence with respect to performing Activity Daily Life. The values assigned to each activity depend on the time spent and help to carry it out. The activities are valued differently, being able to assign 0, 5, 10 or 15 points. The global range can vary between 0, completely dependent, and 100 points, completely independent.

    Time frame: 6 months

06

Study locations

1 site
  • Universidad de La Frontera
    Temuco, 4780000, Chile
07

References and documents

Individual participant data

Plan to share: Undecided — We have not decided this item.

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03459066
Lead sponsor
Universidad de La Frontera
Responsible party
ARLETTE PATRICIA DOUSSOULIN SANHUEZA (Dr. Arlette Doussoulin, Universidad de La Frontera) — Principal investigator
First posted
Mar 8, 2018
Start date
Oct 1, 2018
Primary completion
Mar 30, 2019
Completion
Oct 30, 2020
Last update
Nov 3, 2020

Study contacts

Arlette Doussoulin, PhD
principal investigator · Universidad de La Frontera

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion